Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,104 | 16,455 | 22,976 | 20,705 | 23,498 |
| Marketable Securities | 22,865 | 27,804 | 28,385 | 38,553 | 45,209 |
| TOTAL | $68,809 | $45,336 | $52,509 | $60,561 | $69,843 |
| Non-Current Assets | |||||
| PPE Net | 769 | 906 | 1,048 | 1,119 | 1,278 |
| Investments And Advances | 37,125 | 37,225 | 0 | 0 | 0 |
| Other Non-Current Assets | 2,533 | 2,062 | 2,305 | 2,497 | 2,676 |
| TOTAL | $40,427 | $40,193 | $3,353 | $3,616 | $3,954 |
| Total Assets | $109,236 | $85,529 | $55,862 | $64,177 | $73,797 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,910 | 3,467 | 2,571 | 2,779 | 3,356 |
| Accrued Expenses | 7,891 | 7,604 | 8,404 | 7,798 | 7,429 |
| TOTAL | $13,916 | $12,149 | $12,001 | $11,553 | $11,712 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 935 | 1,232 | 1,511 | 1,784 | 2,050 |
| TOTAL | $935 | $1,232 | $1,511 | $1,784 | $2,050 |
| Total Liabilities | $14,851 | $13,381 | $13,512 | $13,337 | $13,762 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,310 | 38,310 | 28,062 | 28,036 | 27,953 |
| Common Shares | 4 | 3 | 3 | 3 | 3 |
| Retained earnings | -234,720 | -223,140 | -250,487 | -240,691 | -230,080 |
| Other shareholders' equity | 6 | 4 | 12 | 53 | 43 |
| TOTAL | $94,385 | $72,148 | $42,350 | $50,840 | $60,035 |
| Total Liabilities And Equity | $109,236 | $85,529 | $55,862 | $64,177 | $73,797 |